IS8496A - Compositions for the Treatment of Propagating Diseases - Google Patents

Compositions for the Treatment of Propagating Diseases

Info

Publication number
IS8496A
IS8496A IS8496A IS8496A IS8496A IS 8496 A IS8496 A IS 8496A IS 8496 A IS8496 A IS 8496A IS 8496 A IS8496 A IS 8496A IS 8496 A IS8496 A IS 8496A
Authority
IS
Iceland
Prior art keywords
propagating
diseases
compositions
treatment
propagating diseases
Prior art date
Application number
IS8496A
Other languages
Icelandic (is)
Inventor
James M Nichols
Margaret S Lee
Keith Curtis
Zhang Yanzhen
Original Assignee
Combinatorx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/855,130 external-priority patent/US20050100508A1/en
Application filed by Combinatorx Inc filed Critical Combinatorx Inc
Publication of IS8496A publication Critical patent/IS8496A/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225Polycarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/916Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
IS8496A 2003-11-12 2006-06-02 Compositions for the Treatment of Propagating Diseases IS8496A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51955103P 2003-11-12 2003-11-12
US10/855,130 US20050100508A1 (en) 2003-11-12 2004-05-27 Methods for identifying drug combinations for the treatment of proliferative diseases
PCT/US2004/037527 WO2005046607A2 (en) 2003-11-12 2004-11-09 Combinations for the treatment of proliferative diseases

Publications (1)

Publication Number Publication Date
IS8496A true IS8496A (en) 2006-06-02

Family

ID=34556562

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8496A IS8496A (en) 2003-11-12 2006-06-02 Compositions for the Treatment of Propagating Diseases

Country Status (13)

Country Link
EP (1) EP1689352A2 (en)
JP (1) JP2007524657A (en)
KR (1) KR20060118514A (en)
AR (1) AR046841A1 (en)
AU (1) AU2004289311A1 (en)
BR (1) BRPI0416390A (en)
CA (1) CA2545423A1 (en)
IL (1) IL175611A0 (en)
IS (1) IS8496A (en)
NO (1) NO20062358L (en)
RU (1) RU2006120491A (en)
TW (1) TW200526777A (en)
WO (1) WO2005046607A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2990929C (en) * 2008-03-18 2022-04-12 Genentech, Inc. Combinations of an anti-her2 antibody-drug conjugate and chemotherapeutic agents, and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2235420A1 (en) * 1998-06-17 1999-12-17 Paolo Renzi Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation
US6569853B1 (en) * 2000-11-06 2003-05-27 Combinatorx, Incorporated Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders

Also Published As

Publication number Publication date
RU2006120491A (en) 2007-12-20
WO2005046607A3 (en) 2012-12-20
AR046841A1 (en) 2005-12-28
EP1689352A2 (en) 2006-08-16
AU2004289311A1 (en) 2005-05-26
NO20062358L (en) 2006-07-12
BRPI0416390A (en) 2007-02-21
IL175611A0 (en) 2008-04-13
JP2007524657A (en) 2007-08-30
CA2545423A1 (en) 2005-05-26
WO2005046607A2 (en) 2005-05-26
KR20060118514A (en) 2006-11-23
TW200526777A (en) 2005-08-16

Similar Documents

Publication Publication Date Title
DK1644021T3 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DISEASES
DE602005023172D1 (en) HYDANTINE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES
CY2013022I1 (en) COMPOSITIONS FOR THE THERAPEUTIC TREATMENT OF GASTROINTESTINAL DISORDERS
IS8142A (en) Medication useful for the treatment of pain
IS8516A (en) Phosphonates, monophosphonamides, bisphosphonamides for the treatment of viral diseases
DK1708992T3 (en) Sulfonamide derivatives for the treatment of diseases
DK1701941T3 (en) Compounds for the Treatment of Diseases of Cell Proliferation
DE602005007717D1 (en) IMIDAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
IS8398A (en) Drug formulations for the treatment of tumors
ATE434620T1 (en) DIHYDROTHIENOPYRIMIDINES FOR THE TREATMENT OF INFLAMMATORY DISEASES
ATE375977T1 (en) SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES
IS8246A (en) Treatment of neurodegenerative conditions
IS7099A (en) Compounds for the treatment of inflammatory disorders
DK2308507T3 (en) Methods for the treatment of preeclampsia
ATE440866T1 (en) NOGO-A-NEUTRALIZING IMMUNOLOBULINES FOR THE TREATMENT OF NEUROLOGICAL DISEASES
NO20054598D0 (en) Beta-carbolines useful for treating inflammatory diseases
DK1803718T3 (en) 4-Tetrazolyl-4-phenylpiperidine derivatives for the treatment of pain
DK1592384T3 (en) Cop 1 for the treatment of inflammatory bowel diseases
IS8497A (en) Methods and reagents for the treatment of inflammatory diseases
DK1448205T3 (en) Combinations for the treatment of immuno-inflammatory diseases
ATE443704T1 (en) PYRIDOPYRIMIDINONE FOR THE TREATMENT OF CANCER DISEASES
DK1919290T3 (en) Methods and products for the treatment of diseases
NO20045554L (en) Procedure for the treatment of diabetes
IS7444A (en) Morpholinyl-urea derivatives for use in the treatment of inflammatory diseases
EP1611120A4 (en) Novel methods for the treatment of inflammatory diseases